Allianz Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50,096
| Closed | -$1.03M | – | 2043 |
|
|
2021
Q4 | $1.03M | Sell |
50,096
-7,881
| -14% | -$161K | ﹤0.01% | 1594 |
|
|
2021
Q3 | $1.48M | Buy |
57,977
+41,450
| +251% | +$1.06M | ﹤0.01% | 1446 |
|
|
2021
Q2 | $578K | Sell |
16,527
-45,191
| -73% | -$1.58M | ﹤0.01% | 1640 |
|
|
2021
Q1 | $2.06M | Sell |
61,718
-21,462
| -26% | -$715K | ﹤0.01% | 1264 |
|
|
2020
Q4 | $2.16M | Sell |
83,180
-84,500
| -50% | -$2.19M | ﹤0.01% | 1277 |
|
|
2020
Q3 | $1.66M | Buy |
+167,680
| New | +$1.66M | ﹤0.01% | 1297 |
|
|
2019
Q1 | – | Sell |
-461,225
| Closed | -$3.41M | – | 2273 |
|
|
2018
Q4 | $3.41M | Buy |
+461,225
| New | +$3.41M | ﹤0.01% | 1299 |
|
|
2017
Q2 | – | Sell |
-396,075
| Closed | -$2.05M | – | 2120 |
|
|
2017
Q1 | $2.05M | Sell |
396,075
-22,000
| -5% | -$114K | ﹤0.01% | 1491 |
|
|
2016
Q4 | $1.59M | Sell |
418,075
-175,031
| -30% | -$665K | ﹤0.01% | 1544 |
|
|
2016
Q3 | $5.31M | Buy |
+593,106
| New | +$5.31M | 0.01% | 1182 |
|